Should You Keep Taking Zantac for Your Heartburn?

The New York TimesThe heartburn drug Zantac has been on the market for decades, and was considered safe enough to be sold over the counter and regularly given to infants. But last week, the Food and Drug Administration said that it had detected low levels of a ...

September 19th 2019


Novartis stops distribution of Zantac

HealioZantac manufacturer Novartis has stopped the distribution of its heartburn medication across all available markets, including the United States and Canada, Reuters reported. The halt in distribution comes days after the FDA announced that it had found low ...

September 19th 2019


Novartis Stops Distributing Generic Zantac Over Potential Cancer-Causing Ingredient

CBS BostonWASHINGTON (CBS) – Drug maker Novartis has halted distribution of generic versions of Zantac. The popular heartburn medication has been investigated for containing a potential cancer-causing ingredient. A Novartis spokesman told CBS News “our ...

September 19th 2019


Cancer worries halt shipments of generic Zantac

USA TODAYA division of Swiss pharmaceutical maker Novartis is reportedly halting distribution of generic Zantac pills over concerns about an ingredient possibly linked to cancer. Novartis-owned Sandoz has issued a "precautionary distribution stop" of all medicines ...

September 19th 2019


Carcinogen in Zantac and generic heartburn drugs triggers investigations

Los Angeles TimesDrug-safety officials in the United States and Europe said Friday that they were looking into whether Sanofi heartburn medication Zantac and generic versions made by numerous manufacturers contain levels of the probable carcinogen NDMA that could pose ...

September 14th 2019


Zantac Heartburn Drug May Contain Carcinogen: FDA

WebMDFRIDAY, Sept. 13, 2019 (HealthDay News) -- A substance that could cause cancer has been found in some ranitidine heartburn and ulcer medicines, including the brand-name drug Zantac, and the source of this contamination is being investigated, the U.S. ...

September 14th 2019


Zantac has low levels of cancer-causing chemical, FDA warns

CBS NewsThe federal agency said the carcinogenic ingredient is a type of nitrosamine called N-nitrosodimethylamine, or NDMA. The agency said patients can continue taking Zantac and similar heartburn medications for now, but patients using prescription versions ...

September 14th 2019


FDA finds probable carcinogen in Zantac and other heartburn drugs

USA TODAYA probable carcinogen that prompted the recall of several versions of blood pressure-lowering pills has been detected in the heartburn drug Zantac and its generic versions, the Food and Drug Administration said Friday. The FDA and European drug ...

September 14th 2019